accepted and acknowledged
on 28 Apr 2022
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
GB
SG12NY
Serial Number
85769233 filed on 01st Nov 2012
Registration Number
4872584 registered on 22nd Dec 2015
Correspondent Address
Christopher M. Hanes
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmon Read More
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
N/A
N/A
No 85769233
No Service/Collective Mark
No 81240180
Yes
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
22nd Dec 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
27th Jun 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
27th Jun 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
27th Jun 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
27th Jun 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
27th Jun 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
28th Oct 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
28th Oct 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
28th Oct 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
28th Apr 2022 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |